Financials
- Market Capitalization 2.1 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
112.53
Fiyat/satışlar oranı
6.8
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1948 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | -1.15% | -1.69% | +7.88% | +36.55% | 2.17 B USD | ||
| 1961 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.62 USD | -4.13% | -6.76% | +8.18% | +129.58% | 2.13 B USD | ||
| 1975 | ADMA ADMA Biologics Inc - Common Stock | 9.34 USD | -1.48% | -4.69% | +9.62% | -45.35% | 2.09 B USD | ||
| 1994 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.62 USD | -2.98% | -2.07% | +8.10% | +59.78% | 2.04 B USD |